Click on a headline to see stories that shaped it.
Threads
Stories that evolved over the week.
8 threads
Sep 21 - Sep 25across 5 daysImpact
NSE becomes a public-market test
NSE progressed from strong institutional demand to a landmark listing that gave investors direct exposure to India’s dominant exchange. Its public valuation now depends on volume growth, revenue diversification, derivatives recovery and governance credibility.
The Nifty moved into its longest losing streak in years as selling pressure was joined by higher bond yields, rupee weakness and inflation concerns. Foreign capital rotated toward selected debt, IPOs and smaller companies rather than leaving India entirely, leaving large caps under pressure.
Proposed caps on commissions and management expenses triggered a sector selloff and then drove further declines in distribution stocks. The measures could reduce customer-acquisition economics, pressure margins and delay digital insurers’ profitability.
The primary market stayed active, but investor conviction varied widely: some offerings attracted strong demand while others saw muted subscriptions, weak listing signals or withdrawal. The contrast suggests that capital remains available for credible growth stories without supporting every new issue.
SEBI expanded surveillance and enforcement while also broadening portfolio managers’ tools and lowering the PMS entry threshold. The week therefore brought both stricter conduct expectations and a wider route for investors and managers to participate.
Proprietary traders pulled back as tighter conditions weakened derivatives strategies, but NSE said it was beginning to recover equity-derivatives share. Record activity at GIFT Nifty showed that demand for Indian derivatives exposure is also deepening offshore.
Moneyview moved from modest oversubscription to 6.01 times demand by the second day, while its grey-market premium rose to 41%. The stronger listing signal also increased the risk of post-listing volatility and a gap between price and fundamentals.
Varmora’s grey-market premium fell from 6% to zero as subscription reached only 27% after two days. The offering’s recovery case now depends on earnings improvement and debt reduction that investors have not yet endorsed.